Company Filing History:

12 out of 4,455

Pfizer Corporation

patents

3 out of 174

Agouron Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2006-2023

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11780853 - Substituted N-pyrimidin-4-yl-3-aminopyrrolo[3,4-C]pyrazoles as protein kinase C inhibitors (2023-10-10),

2. 11220518 - Substituted n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as protein kinase C inhibitors (2022-01-11),

3. 10316045 - Substituted pyrrolo[3,4-c]pyrazoles as pkc kinase inhibitors (2019-06-11),

4. 9518060 - Substituted pyrrolo[3,4-c]pyrazoles as PKC kinase inhibitors (2016-12-13),

5. 8999981 - [object Object] (2015-04-07),

6. 8877761 - N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors (2014-11-04),

7. 8518952 - 6 substituted 2-heterocyclylamino pyrazine compounds as CHK-1 inhibitors (2013-08-27),

8. 8268835 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same (2012-09-18),

9. 8183255 - N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors (2012-05-22),

10. 8114871 - 3-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivatives (2012-02-14),

11. 7622605 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same (2009-11-24),

12. 7473790 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same (2009-01-06),

13. 7151105 - Inhibitors of Hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same (2006-12-19),

14. 7148226 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same (2006-12-12),

15. 7115658 - Inhibitors of hepatitis C virus RNA-dependent RNA polymerase (2006-10-03),

Title: The Innovative Journey of Hui Li

Introduction: Hui Li, a talented inventor based in Carlsbad, CA, has been making significant contributions to the world of technology and innovation. Her passion for creating groundbreaking solutions has led to numerous patents and collaborations in various industries.

Latest Patents: Hui Li's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar power systems that are more efficient and cost-effective. Her innovative approach to sustainability has garnered attention from experts worldwide.

Career Highlights: With a background in engineering and a keen eye for detail, Hui Li has established herself as a leading figure in the field of clean energy solutions. Her career highlights include receiving prestigious awards for her contributions to environmental innovation and being invited to speak at international conferences.

Collaborations: Hui Li has collaborated with top research institutions and leading companies to further her research and bring her inventions to the market. Her ability to work across disciplines and industries has resulted in groundbreaking technologies that have the potential to shape the future of renewable energy.

Conclusion: In conclusion, Hui Li's dedication to innovation and her commitment to creating a more sustainable world through her inventions make her a true pioneer in the field. Her work continues to inspire others to push the boundaries of what is possible in the realm of clean energy solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com

4 patents pending (EPO):

Please report any incorrect information to support@idiyas.com